FDA expands access to a promising drug for one of the worst cancers - The Washington Post

FDA expands access to a promising drug for one of the worst cancers  The Washington PostF.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer  The New York TimesFDA green lights early access to pancreatic cancer drug, daraxonrasib  USA TodayUS FDA authorizes early access to Revolution's pancreatic cancer pill  ReutersGroundbreaking advancements in pancreatic cancer treatment excite UW Health doctor  WKOW